Bio-View Ltd (BIOV) - Net Assets

Latest as of June 2025: ILA19.93 Million ILA ≈ $53.43K USD

Based on the latest financial reports, Bio-View Ltd (BIOV) has net assets worth ILA19.93 Million ILA (≈ $53.43K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA28.19 Million ≈ $75.57K USD) and total liabilities (ILA8.26 Million ≈ $22.13K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BIOV strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets ILA19.93 Million
% of Total Assets 70.71%
Annual Growth Rate 19.69%
5-Year Change -8.47%
10-Year Change -0.18%
Growth Volatility 106.95

Bio-View Ltd - Net Assets Trend (2009–2024)

This chart illustrates how Bio-View Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is Bio-View Ltd worth.

Annual Net Assets for Bio-View Ltd (2009–2024)

The table below shows the annual net assets of Bio-View Ltd from 2009 to 2024. Also explore Bio-View Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2024-12-31 ILA22.95 Million
≈ $61.52K		 -15.96%
2023-12-31 ILA27.30 Million
≈ $73.20K		 -3.43%
2022-12-31 ILA28.28 Million
≈ $75.81K		 +4.11%
2021-12-31 ILA27.16 Million
≈ $72.82K		 +8.34%
2020-12-31 ILA25.07 Million
≈ $67.21K		 +0.48%
2019-12-31 ILA24.95 Million
≈ $66.89K		 +9.68%
2018-12-31 ILA22.75 Million
≈ $60.99K		 -3.01%
2017-12-31 ILA23.45 Million
≈ $62.88K		 -15.03%
2016-12-31 ILA27.61 Million
≈ $74.01K		 +20.08%
2015-12-31 ILA22.99 Million
≈ $61.63K		 +26.43%
2014-12-31 ILA18.18 Million
≈ $48.75K		 +16.19%
2013-12-31 ILA15.65 Million
≈ $41.95K		 -6.26%
2012-12-31 ILA16.69 Million
≈ $44.76K		 +9.84%
2011-12-31 ILA15.20 Million
≈ $40.75K		 +85.89%
2010-12-31 ILA8.18 Million
≈ $21.92K		 +428.17%
2009-12-31 ILA1.55 Million
≈ $4.15K		 --

Equity Component Analysis

This analysis shows how different components contribute to Bio-View Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 2695800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components ILA49.90 Million 217.48%
Total Equity ILA22.95 Million 100.00%

Bio-View Ltd Competitors by Market Cap

The table below lists competitors of Bio-View Ltd ranked by their market capitalization.

Company Market Cap
Agricore CS Holdings Berhad
KLSE:0309
 $20.37 Million
MetaLabs Co Ltd
KO:090370
 $20.39 Million
IWG PLC
LSE:IWG
 $20.39 Million
Atossa Genetics Inc
NASDAQ:ATOS
 $20.41 Million
Photon Energy N.V.
WAR:PEN
 $20.36 Million
TMD Energy Limited
NYSE MKT:TMDE
 $20.34 Million
Bannari Amman Spinning Mills Limited
NSE:BASML
 $20.32 Million
Sidma S.A. Steel Products
AT:SIDMA
 $20.31 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Bio-View Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 27,305,000 to 22,946,000, a change of -4,359,000 (-16.0%).
  • Net loss of 3,148,000 reduced equity.
  • Share repurchases of 1,400,000 reduced equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ILA-3.15 Million -13.72%
Share Repurchases ILA1.40 Million -6.1%
Other Changes ILA189.00K +0.82%
Total Change ILA- -15.96%

Book Value vs Market Value Analysis

This analysis compares Bio-View Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 450.88x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 47.57x to 450.88x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 ILA1.68 ILA79.90 x
2018-12-31 ILA1.63 ILA79.90 x
2019-12-31 ILA1.75 ILA79.90 x
2020-12-31 ILA1.83 ILA79.90 x
2021-12-31 ILA1.98 ILA79.90 x
2022-12-31 ILA2.07 ILA79.90 x
2023-12-31 ILA0.20 ILA79.90 x
2024-12-31 ILA0.18 ILA79.90 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Bio-View Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -13.72%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -12.27%
  • • Asset Turnover: 0.76x
  • • Equity Multiplier: 1.47x
  • Recent ROE (-13.72%) is below the historical average (14.03%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2009 72.16% 4.96% 1.53x 9.48x ILA962.20K
2010 64.04% 20.68% 1.18x 2.62x ILA4.42 Million
2011 43.27% 25.13% 0.89x 1.94x ILA5.06 Million
2012 8.64% 5.54% 0.87x 1.79x ILA-227.40K
2013 -6.88% -4.67% 0.83x 1.78x ILA-2.64 Million
2014 11.59% 6.97% 0.97x 1.71x ILA289.80K
2015 17.69% 11.77% 1.03x 1.45x ILA1.77 Million
2016 16.07% 13.33% 0.86x 1.40x ILA1.68 Million
2017 -5.34% -4.51% 0.80x 1.48x ILA-3.60 Million
2018 -8.15% -7.33% 0.76x 1.47x ILA-4.13 Million
2019 10.12% 7.06% 0.97x 1.48x ILA30.00K
2020 3.53% 3.41% 0.77x 1.35x ILA-1.62 Million
2021 8.04% 7.16% 0.76x 1.47x ILA-532.00K
2022 2.08% 2.01% 0.70x 1.48x ILA-2.24 Million
2023 1.40% 1.10% 0.83x 1.54x ILA-2.35 Million
2024 -13.72% -12.27% 0.76x 1.47x ILA-5.44 Million

Industry Comparison

This section compares Bio-View Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $71,816,778
  • Average return on equity (ROE) among peers: -136.46%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Bio-View Ltd (BIOV) ILA19.93 Million 72.16% 0.41x $20.36 Million
Allmed Solutions Ltd (ALMD) $52.31 Million 5.37% 0.05x $7.99 Million
Erika Carmel Ltd (BCUR) $42.67 Million -76.32% 0.60x $4.69 Million
Brainsway Ltd (BWAY) $15.58 Million -42.02% 0.65x $422.69 Million
Erech Finance Cahalacha Ltd (EFNC) $5.09 Million -929.49% 1.72x $1.14 Million
Epitomee Medical Ltd (EPIT) $3.98 Million -79.63% 4.36x $32.37 Million
Erika Carmel-Tech Ltd (ERKA) $9.79 Million -59.80% 1.98x $4.98 Million
Human Xtensions Ltd (HUMX) $148.82 Million -19.18% 0.12x $2.12 Million
Ilex Medical (ILX) $214.38 Million -10.36% 1.49x $154.11 Million
Pulsenmore Ltd (PULS) $153.73 Million -16.67% 0.09x $22.89 Million

About Bio-View Ltd

TA:BIOV Israel Medical Devices
Market Cap
$27.74 Million
ILA10.35 Billion ILA
Market Cap Rank
#25137 Global
#360 in Israel
Share Price
ILA79.90
Change (1 day)
-4.20%
52-Week Range
ILA11.90 - ILA131.90
All Time High
ILA5076.00
Categories
Companies in Israel Medical Devices
About

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company's products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatic… Read more